Abstract: Embodiments of the invention include quinoline compounds and methods of synthesis. Ohm-581 has demonstrated dual inhibition of JAK2 and BET and acts as a therapeutic agent for micosis fungoides (MF) and other hematologic malignancies. Embodiments also include an efficient process for the preparation of Ohm-581 and pharmaceutically acceptable salts. The process is suited for large-scale production of quinoline compounds including Ohm-581.
Type:
Application
Filed:
August 9, 2020
Publication date:
October 6, 2022
Applicant:
OHM ONCOLOGY
Inventors:
Ram Shankar Upadhayaya, Murali Krishna Ukkalam, K Narasimha Sarma